Clinical Trial

A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
A clinical study evaluating the pharmacokinetic characteristics and safety of AHB-137 injection in participants with mild to moderate liver dysfunction and those with normal liver function.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-07-30
notable Trial sites expanded: 1 -> 5 locations 2026-07-30
Trial Details
NCT Number NCT07600788
Lead Sponsor Ausper Biopharma Co., Ltd.
Conditions Chronic Hepatitis B
Enrollment 32 participants
Start Date 2026-07-09
Primary Completion 2028-05-15 (estimated)
Study Completion 2028-05-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-29